Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Kinsella

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
American Journal of Clinical Oncology|October 8, 2008
The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancerTimothy J Kinsella, Yuji Seo, Joseph Willis, et al.
Frontiers in Oncology|December 11, 2013
A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal CancerJason Chan, Michael T Kinsella, Joseph E Willis, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinomaRodney J Ellis, Amy Vertocnik, Edward Kim, et al.
Annals of Surgical Oncology|January 19, 2006
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinomaMark S Talamonti, William Small, Mary F Mulcahy, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical studyCraig A Schulz, Minesh P Mehta, Benham Badie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trialWilliam Small, Jordan Berlin, Gary M Freedman, et al.
Cancer|April 25, 2019
National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancerThomas J George, Aaron J Franke, A Bapsi Chakravarthy, et al.
Autophagy|January 12, 2008
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotesDaniel J Klionsky, Hagai Abeliovich, Patrizia Agostinis, et al.
Autophagy|September 12, 2012
Guidelines for the use and interpretation of assays for monitoring autophagyDaniel J Klionsky, Fabio C Abdalla, Hagai Abeliovich, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
American Journal of Clinical Oncology|October 8, 2008
The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancerTimothy J Kinsella, Yuji Seo, Joseph Willis, et al.
Frontiers in Oncology|December 11, 2013
A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal CancerJason Chan, Michael T Kinsella, Joseph E Willis, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinomaRodney J Ellis, Amy Vertocnik, Edward Kim, et al.
Annals of Surgical Oncology|January 19, 2006
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinomaMark S Talamonti, William Small, Mary F Mulcahy, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical studyCraig A Schulz, Minesh P Mehta, Benham Badie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trialWilliam Small, Jordan Berlin, Gary M Freedman, et al.
Cancer|April 25, 2019
National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancerThomas J George, Aaron J Franke, A Bapsi Chakravarthy, et al.
Autophagy|January 12, 2008
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotesDaniel J Klionsky, Hagai Abeliovich, Patrizia Agostinis, et al.
Autophagy|September 12, 2012
Guidelines for the use and interpretation of assays for monitoring autophagyDaniel J Klionsky, Fabio C Abdalla, Hagai Abeliovich, et al.
Pageof 7